HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Zhao Selected Research

wogonin

5/2022Retraction Note: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.
6/2021Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation.
12/2019Corrigendum to "Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein" [Toxicology and Applied Pharmacology 271 (2013) 144-145].
1/2017Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer.
1/2017Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation.
4/2016BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin.
6/2015Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway.
11/2014Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.
10/2014Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.
2/2014Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Zhao Research Topics

Disease

224Neoplasms (Cancer)
12/2022 - 07/2003
53Inflammation (Inflammations)
04/2022 - 01/2009
39Infections
12/2022 - 08/2002
32Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2004
28Breast Neoplasms (Breast Cancer)
10/2022 - 07/2004
27Carcinogenesis
10/2022 - 09/2003
27Neoplasm Metastasis (Metastasis)
11/2021 - 09/2003
26Chronic Obstructive Pulmonary Disease (COPD)
08/2022 - 11/2004
26Hypoxia (Hypoxemia)
01/2022 - 10/2009
21Body Weight (Weight, Body)
12/2022 - 08/2008
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 07/2010
19Wounds and Injuries (Trauma)
07/2022 - 10/2002
19Carcinoma (Carcinomatosis)
03/2022 - 09/2003
19Fibrosis (Cirrhosis)
01/2022 - 01/2004
18Leukemia
03/2021 - 09/2005
17Hypertension (High Blood Pressure)
06/2022 - 03/2006
15Type 2 Diabetes Mellitus (MODY)
12/2022 - 01/2012
15Insulin Resistance
06/2022 - 05/2005
15Lung Neoplasms (Lung Cancer)
04/2022 - 12/2007
14Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 12/2005
13COVID-19
12/2022 - 01/2020
13Obesity
12/2022 - 08/2011
13Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2005
13Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 07/2008
12Ischemia
05/2022 - 01/2005
12Pneumonia (Pneumonitis)
05/2022 - 03/2010
12Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2014
11Stomach Neoplasms (Stomach Cancer)
01/2022 - 06/2005
11Glioblastoma (Glioblastoma Multiforme)
01/2021 - 03/2008
11Urinary Bladder Neoplasms (Bladder Cancer)
10/2018 - 01/2015
10Pain (Aches)
07/2022 - 11/2012
10Alzheimer Disease (Alzheimer's Disease)
01/2021 - 10/2006
10Atherosclerosis
01/2020 - 07/2009
9Cognitive Dysfunction
07/2022 - 01/2014
9Hemorrhage
06/2022 - 02/2013
9Colonic Neoplasms (Colon Cancer)
01/2020 - 08/2012
8Acute Kidney Injury (Acute Renal Failure)
02/2022 - 09/2012
8Acute Lung Injury
01/2022 - 09/2012
8Periodontitis
10/2021 - 10/2014
8Prostatic Neoplasms (Prostate Cancer)
02/2021 - 01/2012
8Melanoma (Melanoma, Malignant)
01/2021 - 08/2010
8Hyperplasia
10/2020 - 04/2002
8Cysts
07/2020 - 08/2010
7Lung Injury
12/2022 - 03/2013
7Traumatic Brain Injuries (Traumatic Brain Injury)
10/2022 - 04/2012
7Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022 - 01/2014
7Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 08/2010
7Stroke (Strokes)
01/2022 - 12/2005
7Hyperalgesia
07/2020 - 11/2012

Drug/Important Bio-Agent (IBA)

105Proteins (Proteins, Gene)FDA Link
12/2022 - 07/2003
48Pharmaceutical PreparationsIBA
12/2022 - 12/2005
35Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2010
27Messenger RNA (mRNA)IBA
05/2022 - 09/2003
27Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2014
24Biological ProductsIBA
02/2022 - 03/2007
21CytokinesIBA
01/2022 - 08/2010
21FlavonoidsIBA
11/2020 - 12/2006
20wogoninIBA
05/2022 - 06/2006
19DNA (Deoxyribonucleic Acid)IBA
09/2022 - 10/2005
18MicroRNAs (MicroRNA)IBA
02/2022 - 01/2012
17Phosphotransferases (Kinase)IBA
01/2022 - 04/2005
16VaccinesIBA
12/2022 - 07/2003
16LipidsIBA
12/2022 - 12/2005
16Doxorubicin (Adriamycin)FDA LinkGeneric
09/2022 - 08/2014
165,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA
11/2020 - 12/2006
15Interleukin-6 (Interleukin 6)IBA
08/2022 - 08/2010
15CateninsIBA
03/2022 - 11/2010
15SmokeIBA
06/2021 - 10/2002
12EnzymesIBA
01/2022 - 08/2004
12Therapeutic UsesIBA
04/2021 - 04/2011
12Small Interfering RNA (siRNA)IBA
11/2020 - 09/2007
11Long Noncoding RNAIBA
01/2022 - 01/2017
11LipopolysaccharidesIBA
01/2022 - 01/2009
11Cisplatin (Platino)FDA LinkGeneric
10/2021 - 03/2013
10Antiviral Agents (Antivirals)IBA
11/2022 - 09/2008
10AntigensIBA
05/2022 - 07/2004
10Peptides (Polypeptides)IBA
09/2020 - 12/2010
9AntioxidantsIBA
01/2022 - 05/2010
9Blood Glucose (Blood Sugar)IBA
01/2022 - 08/2008
9NanodiamondsIBA
09/2021 - 07/2014
9polyglycerolIBA
01/2021 - 07/2014
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 05/2005
9gambogic acidIBA
06/2009 - 07/2004
8Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 08/2009
8CollagenIBA
03/2022 - 04/2002
8Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
01/2017 - 01/2012
7C-Reactive ProteinIBA
01/2022 - 08/2008
7Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2015
7Neuroprotective AgentsIBA
12/2021 - 02/2014
7Eosine Yellowish-(YS) (Eosin)IBA
08/2021 - 01/2012
7salicylhydroxamic acid (SHAM)IBA
07/2020 - 03/2012
7Oxygen (Dioxygen)IBA
01/2020 - 11/2004

Therapy/Procedure

92Therapeutics
05/2022 - 12/2005
32Drug Therapy (Chemotherapy)
10/2022 - 12/2005
11Aftercare (After-Treatment)
05/2022 - 11/2008
8Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2021 - 06/2005
7Intraperitoneal Injections
05/2022 - 06/2010
7Radiotherapy
03/2022 - 07/2013
7Transplantation
11/2021 - 06/2004
7Ligation
09/2021 - 08/2016